Two inhibitors of hepatitis C proteins given as a single-pill combination are over 90% effective against the virus, according to a phase II study in the Lancet .
http://www.jwatch.org//fw108118/2013/11/06/combination-therapy-hep-c-yields-promising-phase-ii?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+PhysiciansFirstWatch+%28Physician%27s+First+Watch%3A+Current+Issue%29
http://www.jwatch.org//fw108118/2013/11/06/combination-therapy-hep-c-yields-promising-phase-ii?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+PhysiciansFirstWatch+%28Physician%27s+First+Watch%3A+Current+Issue%29
No comments:
Post a Comment